Cancer Epigenetics
Risk Assessment, Diagnosis, Treatment, and Prognosis
This volume shares technologies that detect common epigenetic changes which are very important in the early detection, progression, and prognosis of cancer as well as the design of new therapeutic tools against cancer cells. Beginning with a bit of background on epigenetic mechanisms, Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis continues with cancer specific type epigenetic change, methods and technologies used for detecting epigenetic changes, factors that influence epigenetic changes in cancer, as well as a final section on future directions in the field. Written for the highly successful Methods in Molecular B…
Mehr
CHF 211.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
- ISBN: 978-1-4939-4894-9
- EAN: 9781493948949
- Produktnummer: 20404875
- Verlag: Springer New York
- Sprache: Englisch
- Erscheinungsjahr: 2016
- Seitenangabe: 820 S.
- Masse: H25.4 cm x B17.7 cm x D4.8 cm 1'499 g
- Auflage: Softcover reprint of the original 1st ed. 2015
- Abbildungen: Paperback
- Gewicht: 1499
13 weitere Werke von Mukesh (Hrsg.) Verma:
Progress and Challenges in Precision Medicine
Risk Assessment, Diagnosis, Treatment, and Prognosis
Risk Assessment, Diagnosis, Treatment, and Prognosis
Ebook (EPUB Format)
CHF 139.30
Cancer Biomarkers
Risk Assessment, Diagnosis, Treatment, and Prognosis
Risk Assessment, Diagnosis, Treatment, and Prognosis
Ebook (PDF Format)
CHF 110.30
Bewertungen
Anmelden